177 related articles for article (PubMed ID: 21345672)
1. Synthesis, biological evaluation and molecular docking studies of stellatin derivatives as cyclooxygenase (COX-1, COX-2) inhibitors and anti-inflammatory agents.
Gautam R; Jachak SM; Kumar V; Mohan CG
Bioorg Med Chem Lett; 2011 Mar; 21(6):1612-6. PubMed ID: 21345672
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory, cyclooxygenase (COX)-2, COX-1 inhibitory, and free radical scavenging effects of Rumex nepalensis.
Gautam R; Karkhile KV; Bhutani KK; Jachak SM
Planta Med; 2010 Oct; 76(14):1564-9. PubMed ID: 20379952
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory, cyclooxygenase (COX)-2, COX-1 inhibitory and antioxidant effects of Dysophylla stellata Benth.
Gautam R; Srivastava A; Jachak SM; Saklani A
Fitoterapia; 2010 Jan; 81(1):45-9. PubMed ID: 19632309
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents.
Selvam C; Jachak SM; Thilagavathi R; Chakraborti AK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1793-7. PubMed ID: 15780608
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.
Dube PN; Bule SS; Mokale SN; Kumbhare MR; Dighe PR; Ushir YV
Chem Biol Drug Des; 2014 Oct; 84(4):409-19. PubMed ID: 24636540
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
8. Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents.
Manivannan E; Chaturvedi SC
Bioorg Med Chem; 2011 Aug; 19(15):4520-8. PubMed ID: 21724403
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Zebardast T; Daraie B; Hedayati M
Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
[TBL] [Abstract][Full Text] [Related]
12. Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory-antimicrobial agents and their docking studies with COX-1/COX-2 active sites.
Chandak N; Kumar P; Kaushik P; Varshney P; Sharma C; Kaushik D; Jain S; Aneja KR; Sharma PK
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):476-84. PubMed ID: 23777557
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents.
Bekhit AA; Fahmy HT; Rostom SA; El-Din A Bekhit A
Eur J Med Chem; 2010 Dec; 45(12):6027-38. PubMed ID: 20970223
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents.
Özadalı K; Özkanlı F; Jain S; Rao PP; Velázquez-Martínez CA
Bioorg Med Chem; 2012 May; 20(9):2912-22. PubMed ID: 22475926
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of dithiolethiones as novel cyclooxygenase inhibitors.
Zanatta SD; Manallack DT; Jarrott B; Williams SJ
Bioorg Med Chem Lett; 2009 Jan; 19(2):459-61. PubMed ID: 19056264
[TBL] [Abstract][Full Text] [Related]
17. New racemosol derivatives as potent cyclooxygenase (COX) inhibitors.
Songarsa S; Rajviroongit S; Sae-Tang D; Hannongbua S; Kirtikara K; Kittakoop P
Chem Biodivers; 2005 Dec; 2(12):1635-47. PubMed ID: 17191960
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R
Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; ElTahir KE
Bioorg Med Chem; 2012 May; 20(10):3306-16. PubMed ID: 22516672
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity.
Anzini M; Rovini M; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Giordani A; Makovec F; Anzellotti P; Patrignani P; Biava M
J Med Chem; 2008 Aug; 51(15):4476-81. PubMed ID: 18598017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]